NCT01411449View on ClinicalTrials.gov

Primovist Post-marketing Surveillance in Japan

CompletedOBSERVATIONAL

Enrollment

2,030

Participants

Timeline

Start Date

March 11, 2008

Primary Completion Date

December 14, 2010

Study Completion Date

February 18, 2015

Conditions

Diagnostic Imaging

Interventions

DRUG

Gadoxetic Acid Disodium (Primovist, BAY86-4873)

Patients who will need to undergo contrast enhanced MRI with Primovist

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY